Regrets were had, mistakes were made, but gosh-darn-it, they’re gonna resubmit that retracted paper in the future.
Such is the message from a retraction of “Tsg101 Interacts with Herpes Simplex Virus 1 VP1/2 and Is a Substrate of VP1/2 Ubiquitin-Specific Protease Domain Activity,” from Italian virologists who admitted to copying and pasting their way into the Journal of Virology: Continue reading Authors hit for image manipulation cycle, but don’t worry, they’ll resubmit retracted paper
Experimental & Molecular Medicine has retracted a 2012 paper on stroke by a group of South Korean researchers after learning that one of the figures in the article was unreliable.
The article was titled “Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury,” and it came from a team at Hallym University in Chunchon.
According to the retraction notice: Continue reading Updated: Integrity “uncertain,” journal retracts stroke paper
A group of pharmacology researchers in the UK has lost two papers after submitting effectively identical versions to different journals — and getting them accepted, of course — just a day apart.
The first article appeared on the British Journal of Pharmacology‘s website on July 10, 2012. It was titled “Exendin-4 reverts behavioural and neurochemicaldysfunction in a pre-motor rodent model of Parkinson’s disease with noradrenergic deficit.”
Paper 2 appeared in the journal Neuropeptides in October, although it has an online pub date of August 24, and was titled “Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions.”
Continue reading Duplicate submission costs authors two papers on Parkinson’s disease
The American Heart Association (AHA) is retracting five studies by Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher, that it had subjected to an expression of concern last year.
Here’s the notice: Continue reading Cardiology journals retract five Matsubara studies
Industrial and Corporate Change is the site of management professor Ulrich Lichtenthaler’s 12th retraction.
Here’s the notice for “Outward knowledge transfer: the impact of project-based organization on performance,” originally published in 2010: Continue reading Ulrich Lichtenthaler now up to 12 retractions
The European Journal of Pharmacology has — against its will, it would seem — retracted a 2012 paper by a group of Chinese heart researchers embroiled in a what appears to be a rather messy authorship dispute.
The article, “The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat,” came from the Institute of Cardiovascular Disease at Tongji Hospital, part of of Huazhong University of Science and Technology.
As the retraction notice states:
Continue reading Author break prompts retraction of bone protein paper
The editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures.
The article, “Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment,” purported to show that:
tumor-specific antigens present on exosomes can be presented by DCs [dendritic cells] derived from unrelated umbilical cord blood to induce tumor specific cytotoxicity and this may represent as a novel immunotherapy for ovarian cancer.
But according to William C. S. Cho, editor of the journal, there’s reason to doubt the conclusions. As the notice explains:
Continue reading Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal
Cell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned.
The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as Peer1, identified “several examples of image reuse which might be of interest to PubPeer members and readers:” Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper
Amid an ongoing investigation, a group of psychology researchers at the University of Leuven (KU Leuven) in Belgium have taken a painful decision to retract a paper now that they’ve realized there were serious problems with one aspect of the work.
Here’s the notice for “The Emergence of Orthographic Word Representations in the Brain: Evaluating a Neural Shape-Based Framework Using fMRI and the HMAX Model,” by Wouter Braet, Jonas Kubilius, Johan Wagemans, and Hans P. Op de Beeck: Continue reading Doing the right thing: Psychology researchers retract after realizing data “were not analyzed properly”
Jesús Lemus — the veterinary researcher whose work colleagues have had trouble verifying, including being unable to confirm the identity of one of his co-authors — has notched his ninth retraction.
It’s a clear and comprehensive notice, from the Journal of Applied Ecology, despite the bizarre nature of the case: Continue reading “Ephemeral nature” of samples — and co-author — leads to ninth Jesús Lemus retraction